| Value | ₹0.08 Cr |
|---|
NSE filing, NSE: ERIS. Summary written from the filing by ALFA Finder's alert engine.
Eris Lifesciences Ltd: key numbers
- Share price
- ₹1,275.10
- Market cap
- ₹17,691 Cr
- Revenue (annual)
- ₹3,129 Cr
- Net profit (annual)
- ₹619.5 Cr
- P/E (TTM)
- 25.0×Sector 43.8×
- Promoter holding
- 54.74%+0.60% QoQ
- FII holding
- 5.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eris Lifesciences Ltd
All →Eris Lifesciences Annual General Meeting
Eris Lifesciences has issued a postal ballot notice seeking members' approval to appoint Mr. Akhil Awasthi as Independent Director for five years from 26 September 2026. E-voting runs 6 November to 5 December 2026.
- Execution
- 26 September 2026 to 25 September 2031
Eris Lifesciences Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹892 Cr (+12.6%), PAT ₹187 Cr (+39.2%), EBITDA margin 34.7%. H1 PAT ₹330 Cr (+27.3%). Zorvia out-licensing supports DBF gross margin.
Eris Lifesciences Q2 FY27 Results: Net Profit ₹187.1 Cr, Up 39.1% YoY
Eris Lifesciences Ltd reported revenue from operations of ₹892.4 Cr (+12.6% YoY) and net profit of ₹187.1 Cr (+39.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹187.1 Cr · +39.1% YoY
Eris Lifesciences Board Meeting Date
Eris Lifesciences has scheduled a board meeting for October 26, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ending September.
Eris Lifesciences Other Announcement
Eris Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Eris Lifesciences Debt & Borrowing: ₹1,250 Cr
Eris Lifesciences Limited submitted its half-yearly reporting of debt securities for the period ended September 30, 2026. Two tranches of NCDs totaling ₹1,250 Crore remain outstanding.
- Value
- ₹1,250 Cr
Other legal & regulatory announcements
All →SRG Housing Finance Legal & Regulatory
SRG Housing Finance will miss the 14 November 2026 deadline for its September 2026 half-year results. The delay is due to a forensic audit initiated by the National Housing Bank.
Cupid Breweries & Distilleries Legal & Regulatory
Cupid Breweries received a SEBI administrative warning letter dated 6 November 2026 for a SAST Regulation 22(2A) violation over preferential allotment shares credited to personal demat accounts. The company states there was no financial or operational impact.
Hindustan Copper Legal & Regulatory
Hindustan Copper sought exemption from BSE and NSE fines of Rs.14.43 lakh each for board-composition non-compliance. Four independent director vacancies await Government appointment.
- Value
- ₹0.29 Cr
Flex Foods Legal & Regulatory
Flex Foods Ltd noted a BSE fine of Rs. 86,000 plus GST of Rs. 15,480 for a Regulation 17(1A) breach. The company has paid the fine and applied to BSE for a waiver.
- Value
- ₹0.01 Cr
Burnpur Cement Legal & Regulatory
Burnpur Cement board commented on NSE/BSE fines for a Reg 31A reclassification delay in August 2026. The company says the lapse was not wilful and has sought a fine waiver, which is pending.
DCW Legal & Regulatory
The Madras High Court Madurai Bench dismissed the Government's writ appeal over DCW's land allotment. No settlement amount or financial impact is quantified.